EUROPEAN CANCER PATIENT COALITION -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:700-800
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 19
As coordinator: 0
As participant: 19
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 36.523.122 788.125 4
2020 0 16.194.901 395.104 2
2019 0 31.888.742 552.812 5
2018 0 9.727.723 79.994 2
2017 0 19.404.068 225.957 4
2016 0 11.782.965 246.250 2

Networking:

Partners:

Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM7
TTOPSTART BV7
JANSSEN PHARMACEUTICA NV5
STICHTING VUMC5
BAYER4
F HOFFMANNLA ROCHE4
KATHOLIEKE UNIVERSITEIT LEUVEN4
PFIZER LIMITED4
ASTELLAS PHARMA EUROPE BV3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
NOVARTIS PHARMA3
STICHTING KATHOLIEKE UNIVERSITEIT3
TECHNISCHE UNIVERSITAET MUENCHEN3
UNIVERSITA VITASALUTE SAN RAFFAELE3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY COLLEGE LONDON3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ACADEMISCH ZIEKENHUIS GRONINGEN2
AMGEN2
ASSOCIATION EISBM2
CELGENE MANAGEMENT SARL2
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ELI LILLY AND COMPANY LIMITED2
ERASMUS UNIVERSITEIT ROTTERDAM2
EUROPEAN ASSOCIATION OF PALLIATIVE CARE2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
HEALTH INNOVATION VENTURES BV2
HOSPITAL CLINIC DE BARCELONA2
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE2
ISTITUTO EUROPEO DI ONCOLOGIA2
KING'S COLLEGE LONDON2
LUND UNIVERSITY2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
MERCK SHARP & DOHME CORP2
ONCORADIOMICS2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
STICHTING EUROPEAN UROLOGICAL FOUNDATION2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
TARTU ULIKOOL2
THE GENERAL HOSPITAL CORPORATION2
THE UNIVERSITY OF LIVERPOOL2
UNIVERSIDAD DE NAVARRA2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITY OF ABERDEEN2
UNIVERSITY OF CAMBRIDGE2
UNIVERSITY OF HELSINKI2
UPPSALA UNIVERSITET2
VRIJE UNIVERSITEIT BRUSSEL2
ABBVIE1
ABBVIE INC1
ACADEMISCH ZIEKENHUIS MAASTRICHT1
ACTELION PHARMACEUTICALS1
ALEXANDER FLEMING1
ALTRANPORTUGAL1
AMGEN LIMITED1
AMPHERA BV1
ANAXOMICS BIOTECH S L1
ANTAROS MEDICAL AB1
ARISTOTELIAN UNIVERSITY OF THESSALONIKI1
ARTTIC INNOVATION1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
ASTRAZENECA AB1
AZIENDA UNITA SANITARIA LOCALE DI REGGIO EMILIA1
BAYER AKTIENGESELLSCHAFT1
BAYER PHARMA1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIOSCI CONSULTING BVBA1
BIOXPEDIA AS1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CABALLERO LLANO CARMELO CESAR1
CANCER INTELLIGENCE LIMITED1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRE OSCAR LAMBRET1
CERATIUM BV1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
CLINIQUE UNIVERSITAIRE SAINTLUC ASBL1
CLINIQUES UNIVERSITAIRES SAINTLUC1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
COVANCE LABORATORIES1
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY1
CSL BEHRING1
CYBERLENS BV1
DANMARKS TEKNISKE UNIVERSITET1
DEUTSCHE KREBSGESELLSCHAFT EV1
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG1
DIN DEUTSCHES INSTITUT FUER NORMUNG EV1
DRESDEN UNIVERSITY OF TECHNOLOGY1
DUALTPHARMA1

Constancy:

Total number of partners: 355
Partner loyalty:
Frequent Partner: (> 2 projects): 64
Rare Partner: 291
Frequent / Rare Partner Ratio: 0.22

Project overview:

Start dateProjectacronymrolefundingpartners
2021-10-01Optimal treatment for patients with solid tumours in Europe through Artificial intelligence OPTIMAparticipant10.459.99737
2021-02-01Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine TIGERparticipant6.900.0008
2021-01-01International consortium for integrative genomics prediction INTERVENEparticipant10.434.94018
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-01-01Integrated and standardized NGS workflows for Personalised therapy Instand-NGS4Pparticipant10.998.12822
2020-01-01Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management QUALITOPparticipant5.196.77316
2019-12-01A Collective Intelligence Platform to Support Cancer Champions LifeChampsparticipant4.999.91516
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-01-01CeLac and European consortium for a personalized medicine approach to Gastric Cancer LEGACyparticipant3.577.43111
2019-01-01Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial DIAdICparticipant4.277.87511
2019-01-01The use of proportional palliative sedation for the relief of refractory symptoms: an international multicenter study PalliativeSedationparticipant4.033.52010
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00034
2018-01-01European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools ELBAparticipant3.727.72321
2017-12-01A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer IMMUNISAparticipant6.000.0006
2017-10-01A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology PREDICTparticipant3.860.06018
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer IMMUNOSABRparticipant5.994.17617
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-01-01DC-based immunotherapy to treat Malignant Mesothelioma H2020MM04participant5.782.9658